Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Age-related Macular Degeneration
100%
Multifocal Pupillography
100%
Retinal Function
100%
Ranibizumab
100%
Objective Perimetry
60%
Intravitreal Ranibizumab
60%
Response Time
40%
Peak Response
40%
Extrafoveal
40%
Treatment Outcome
20%
Large Group
20%
Functional Improvement
20%
Multiple Linear Regression Model
20%
Constriction
20%
Time to Peak
20%
Mean Effect
20%
Video Camera
20%
Visual Field
20%
Infrared Illumination
20%
Pupil Response
20%
Best Medical Treatment
20%
Retinal Thickness
20%
Myopic Choroidal Neovascularization (mCNV)
20%
Prognostic Marker
20%
Stimulus Type
20%
Nursing and Health Professions
Age Related Macular Degeneration
100%
Pupillography
100%
Ranibizumab
100%
Perimetry
50%
Treatment Outcome
16%
Visual Field
16%
Ligation
16%
Subretinal Neovascularization
16%
Erethism
16%
Central Retinal Thickness
16%
Efficacy
16%
Medicine and Dentistry
Age Related Macular Degeneration
100%
Pupillography
100%
Ranibizumab
100%
Visual Field Test
50%
Ligation
16%
Visual Field
16%
Choroidal Neovascularization
16%
Hypersensitivity
16%
Treatment Outcome
16%
Neuroscience
Age-Related Macular Degeneration
100%
Ranibizumab
100%
Choroidal Neovascularization
16%